Elan Corp Plc Insider Profile
4 Followers
Elan Corp Plc, Ten Percent Owner at Lipocine, holds 800.39K shares in Lipocine (Ticker: LPCN), holds 3.18M shares in Prothena (Ticker: PRTA), holds 7.75M shares in Alkermes (Ticker: ALKS). Most recently, Elan Corp Plc Bought ― shares of Lipocine on Aug 02, 2013 for an estimated value of ―.
Elan Corp Plc's Trading History
| LPCNLipocine | Aug 02, 2013 | Ten Percent Owner | Informative Buy | ― | $1.37M | |
| PRTAProthena | Dec 28, 2012 | Ten Percent Owner | Informative Buy | ― | $25.97M | |
| ALKSAlkermes | Mar 14, 2012 | Ten Percent Owner | Informative Sell | 381.57M | $364.48M | |
| LGNDLigand Pharma | ― | Ten Percent Owner | ― | $0.00 | ||
| SNGXSoligenix | ― | Ten Percent Owner | ― | $52.19K | ||
| TGENTecogen | ― | Ten Percent Owner | ― | $23.04M |
You May Also Like
Elan Corp Plc insider profile FAQ
What is the percentage of profitable transactions made by Elan Corp Plc?
The percentage of profitable transactions made by Elan Corp Plc is 50%.
What is the average return per transaction made by Elan Corp Plc?
The average return per transaction made by Elan Corp Plc is 43.70%.
What stocks does Elan Corp Plc hold?
Elan Corp Plc holds: LPCN, ALKS, TGEN, PRTA, SNGX, LGND stocks.
What was Elan Corp Plc's most profitable transaction?
Elan Corp Plc’s most profitable transaction was an Informative Buy of PRTA stock on December 28, 2012. The return on the trade was 295.90%.
What is Elan Corp Plc's role in Lipocine?
Elan Corp Plc's role in Lipocine is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
